Delivery Order SPE2DR25D7059-SPE2DR26F7MHF
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 9, 2025, for the supply of Lyrica 100 mg capsules (90-count units) with a ceiling value of $1,853.49. This firm fixed-price delivery order, which is set to be completed by September 10, 2025, represents a small-value pharmaceutical procurement supporting federal medical supply needs. The contract is non-competitive and issued as a child order under AmerisourceBergen's larger Indefinite Delivery...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Lyrica 225 mg capsules (90-count unit) on October 22, 2025, with a ceiling value of $2,797.96 and an ultimate completion date of October 23, 2025. This is a firm fixed-price, non-set-aside contract with performance at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order is issued under the company's larger Indefinite Delivery Contract with DLA Troop...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 11, 2025, for the supply of Lyrica 200 mg capsules (90-count units) under a firm fixed-price contract with a ceiling value of $3,427.94. This non-set-aside award represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical, valued at $999.99 billion and extending through December 2026. The delivery is scheduled for completion by August 12,...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 25, 2025, for the supply of Lyrica 100 mg capsules (quantity 90) with a ceiling value of $11,191.13. This firm fixed price delivery order, which represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (valued at $999,999,999.00 through December 2026), was competitively awarded with no set-aside designation. The ultimate completion date is...
- AmerisourceBergen Drug Corp was awarded a delivery order contract by the Defense Logistics Agency (DLA) on July 24, 2025, for the supply of Lyrica 300 mg capsules (90-count). The contract carries a ceiling value of $1,179.94 under firm fixed pricing terms, with an ultimate completion date of July 25, 2025. This non-competitive delivery order is being fulfilled from AmerisourceBergen's place of performance in Conshohocken, Pennsylvania. The award represents a child contract issued under a...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 15, 2025, for the supply of Lyrica (pregabalin) 100 mg capsules in a quantity of 90 units, with a ceiling value of $11,301.69. This delivery order is a firm fixed price contract with no set-aside designation, indicating it was competitively awarded. The contract is scheduled for completion by September 16, 2025, and will be performed at AmerisourceBergen's corporate office location in...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order by the Defense Logistics Agency on September 9, 2025, for the supply of Lyrica 200 mg capsules (90-count units). The contract is valued at $4,215.55 and is structured as a firm fixed-price delivery order with an ultimate completion date of September 10, 2025. This award represents a non-set-aside, competitively awarded contract and serves as a child order...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on November 6, 2025, for the supply of Lyrica 225 mg capsules (90-count units) with a ceiling value of $1,180.72. This is a firm fixed-price delivery order issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December 2026. The award is non-set-aside and was competitively awarded, reflecting...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Lyrica 100 mg capsules (unit dose, 100 count) on August 20, 2025, with an ultimate completion date of August 21, 2025. This is a firm fixed price delivery order with a ceiling value of $1,128.56 and represents a child contract under AmerisourceBergen's larger indefinite delivery contract with DLA. The award was made through open competition with no set-aside designation. AmerisourceBergen, headquartered in...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 28, 2025, for the supply of Lyrica 50 mg capsules (90-count units) at a ceiling value of $1,182.32. This competitively awarded, non-set-aside contract employs firm fixed pricing and is classified as a delivery order, with an ultimate completion date of July 29, 2025. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor and critical vendor for...
- SPE2DR25D7059Indefinite Delivery Contract
- SPE2DR25D7059-SPE2DR26F7MHFDelivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on November 25, 2025, for the supply of Lyrica 300 mg capsules (90-count units) with a ceiling value of $1,713.51. This firm fixed-price delivery order, with an ultimate completion date of November 26, 2025, represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. The award was made on a competitive basis with no set-aside designation, leveraging the vendor's established pharmaceutical supply capabilities within the federal medical procurement framework. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, serves as a critical pharmaceutical distributor for the Department of Defense and military healthcare systems. The company's federal contract portfolio demonstrates extensive experience supplying a comprehensive range of medications including neurological treatments, pain management pharmaceuticals, and specialty medical products across multiple therapeutic domains. This delivery order for Lyrica, a neurological medication, exemplifies the company's role in supporting military medical supply chains through the DLA's pharmaceutical prime vendor program, which serves the Defense Health Agency, U.S. Coast Guard, and other federal healthcare entities globally.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.7k | 11/24/25 |